Selskabets formål er at drive forskning, udvikling og salg af medikoteknikse apparater og hermed beslægtet virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 7.2 mio. | -1.4 mio. | 8 mio. | -4.9 mio. | 4 | |
CVR: 40958169
Secondary names: Innovision ApS, PulmoTrace ApS, InnoCC ApS
Compared to 52 companies in Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr
Comparison is based on industry median values
COSMED Nordic ApS is currently facing significant financial challenges, with a declining revenue trend from 10.1 million DKK in 2022 to 7.16 million DKK in 2024, alongside increasing losses. The company reported a profit loss of 1.35 million DKK in 2024, marking a substantial deterioration from a loss of 544,761 DKK in 2023. Its equity position has also worsened, dropping to -4.93 million DKK, indicating ongoing financial instability. With its focus on manufacturing radiation and electromedical equipment, COSMED Nordic ApS is struggling to establish a strong foothold in a competitive industry, raising concerns about its long-term viability.
AI-generated summary
Companies in the same industry and area
CVR 41572760
CVR 31826063
CVR 32931235
CVR 34901791
CVR 32999328
companydata.dk